6

CIC-AMERICA Signed CV.pdfEvaluate Patient Preference of Movantik versus Polyethylene Glycol 3350 (PEG3350) for Opioid-lnduced Constipation (OIC) Treatment (D3820L00017) 25. A Phase

  • Upload
    others

  • View
    4

  • Download
    0

Embed Size (px)

Citation preview

Page 1: CIC-AMERICA Signed CV.pdfEvaluate Patient Preference of Movantik versus Polyethylene Glycol 3350 (PEG3350) for Opioid-lnduced Constipation (OIC) Treatment (D3820L00017) 25. A Phase
Page 2: CIC-AMERICA Signed CV.pdfEvaluate Patient Preference of Movantik versus Polyethylene Glycol 3350 (PEG3350) for Opioid-lnduced Constipation (OIC) Treatment (D3820L00017) 25. A Phase
Page 3: CIC-AMERICA Signed CV.pdfEvaluate Patient Preference of Movantik versus Polyethylene Glycol 3350 (PEG3350) for Opioid-lnduced Constipation (OIC) Treatment (D3820L00017) 25. A Phase
Page 4: CIC-AMERICA Signed CV.pdfEvaluate Patient Preference of Movantik versus Polyethylene Glycol 3350 (PEG3350) for Opioid-lnduced Constipation (OIC) Treatment (D3820L00017) 25. A Phase
Page 5: CIC-AMERICA Signed CV.pdfEvaluate Patient Preference of Movantik versus Polyethylene Glycol 3350 (PEG3350) for Opioid-lnduced Constipation (OIC) Treatment (D3820L00017) 25. A Phase
Page 6: CIC-AMERICA Signed CV.pdfEvaluate Patient Preference of Movantik versus Polyethylene Glycol 3350 (PEG3350) for Opioid-lnduced Constipation (OIC) Treatment (D3820L00017) 25. A Phase